Entity Public Float of IGC Pharma, Inc. from 30 Sep 2011 to 30 Sep 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
IGC Pharma, Inc. quarterly Entity Public Float in USD history and change rate from 30 Sep 2011 to 30 Sep 2024.
  • IGC Pharma, Inc. Entity Public Float for the quarter ending 30 Sep 2024 was $29,724,689, a 42% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $29,724,689 +$8,841,952 +42% 30 Sep 2024 10-K 27 Jun 2025 2025 FY
Q3 2023 $20,882,737 +$69,987 +0.34% 30 Sep 2023 10-K 24 Jun 2024 2024 FY
Q3 2022 $20,812,750 -$49,563,276 -70% 30 Sep 2022 10-K 07 Jul 2023 2023 FY
Q3 2021 $70,376,026 +$32,329,063 +85% 30 Sep 2021 10-K 23 Jun 2022 2022 FY
Q3 2020 $38,046,963 +$3,252,423 +9.3% 30 Sep 2020 10-K 14 Jun 2021 2021 FY
Q3 2019 $34,794,540 -$158,205,460 -82% 30 Sep 2019 10-K 13 Jul 2020 2020 FY
Q3 2018 $193,000,000 +$184,623,105 +2204% 28 Sep 2018 10-K 14 Jun 2019 2019 FY
Q3 2017 $8,376,895 -$409,065 -4.7% 29 Sep 2017 10-K 21 Jun 2018 2018 FY
Q3 2016 $8,785,960 +$6,368,523 +263% 30 Sep 2016 10-K 14 Jul 2017 2017 FY
Q3 2015 $2,417,437 -$4,087,348 -63% 30 Sep 2015 10-K 14 Jul 2016 2016 FY
Q3 2014 $6,504,785 $0 0% 30 Sep 2014 10-K 14 Jul 2015 2015 FY
Q3 2013 $6,504,785 -$3,800,167 -37% 30 Sep 2013 10-K 15 Jul 2014 2014 FY
Q3 2012 $10,304,952 +$7,072,074 +219% 30 Sep 2012 10-K 15 Jul 2014 2013 FY
Q3 2011 $3,232,878 30 Sep 2011 10-K 16 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.